Invention Grant
- Patent Title: Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
-
Application No.: US15139924Application Date: 2016-04-27
-
Publication No.: US10011629B2Publication Date: 2018-07-03
- Inventor: Steven J. Coats , Franck Amblard , Seema Mengshetti , Hao Li , Raymond F. Schinazi
- Applicant: Cocrystal Pharma, Inc. , Emory University
- Applicant Address: US GA Tucker US GA Atlanta
- Assignee: Cocrystal Pharma, Inc.,Emory University
- Current Assignee: Cocrystal Pharma, Inc.,Emory University
- Current Assignee Address: US GA Tucker US GA Atlanta
- Agency: Hunton Andrews Kurth LLP
- Agent David Bradin
- Main IPC: C07H19/06
- IPC: C07H19/06 ; C07H19/10 ; C07H19/16 ; A61K9/00 ; A61K9/14 ; A61K45/06 ; A61K31/7072
Abstract:
The present invention is directed to compounds, compositions and methods for treating or preventing Flaviviridae family of viruses (including HCV, Yellow fever, Dengue, Chikungunya and West Nile virus), RSV, HEV, and influenza infection and cancer in human subjects or other animal hosts.
Public/Granted literature
- US20170233428A1 NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER Public/Granted day:2017-08-17
Information query
IPC分类:
